About BioSerenity
BioSerenity is a company based in Paris (France) founded in 2014. BioSerenity has raised $120.96 million across 4 funding rounds from investors including Dassault Systems, Bpifrance and Idinvest Partners. BioSerenity offers products and services including Neuronaute, ICECap, and EEG Platform. BioSerenity operates in a competitive market with competitors including Ceribell, Empatica, INBRAIN Neuroelectronics, Sleepiz and BrainScope, among others.
- Headquarter Paris, France
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioserenity Medical Devices Group
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$120.96 M (USD)
in 4 rounds
-
Latest Funding Round
$25.64 M (USD), Private Equity Round
Nov 13, 2023
-
Investors
Dassault Systems
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioSerenity
BioSerenity offers a comprehensive portfolio of products and services, including Neuronaute, ICECap, and EEG Platform.
Compact device for real-time EEG monitoring and remote diagnostics.
Adaptable caps for EEG devices from neonates to adults.
Platform for uploading and accessing EEG data remotely.
People of BioSerenity
Unlock access to complete
Funding Insights of BioSerenity
BioSerenity has successfully raised a total of $120.96M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round of $25.64 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioSerenity
BioSerenity has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Dassault Systems, Bpifrance and Idinvest Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on buyouts of tech-driven companies
|
Locked | Locked | Locked | |
|
Private equity investments are made in France and the US.
|
Locked | Locked | Locked | |
|
Equity investments are provided to low and middle market companies.
|
Locked | Locked | Locked |
Investor details for BioSerenity
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioSerenity
Investment portfolio details for BioSerenity
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioSerenity
Detailed financials for BioSerenity
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioserenity Comparisons
Peer comparison for BioSerenity
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioSerenity
BioSerenity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Empatica, INBRAIN Neuroelectronics, Sleepiz and BrainScope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Developer of a wrist band to monitor physiological signals
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Provider of an AI-based sleep monitoring device for patients and physicians
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
Detailed competitors of BioSerenity
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioserenity
Complete news archive for BioSerenity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioSerenity
BioSerenity was founded in 2014 and raised its 1st funding round 1 year after it was founded.
BioSerenity is headquartered in Paris, France.
BioSerenity is a funded company, having raised a total of $120.96M across 4 funding rounds to date.
BioSerenity was founded in 2014 in Paris, France, within the healthcare sector. Operations focus on software for managing sleep and EEG laboratories, including scheduling, home sleep testing processing, and remote patient interactions. An EEG device called ICECAP is also offered for inpatient and outpatient use. These tools support healthcare providers in streamlining diagnostic workflows.
BioSerenity's top competitors include Ceribell, Empatica and INBRAIN Neuroelectronics.
BioSerenity offers Neuronaute, ICECap, and EEG Platform.
BioSerenity has 6 investors. Key investors include Dassault Systems, Bpifrance, Idinvest Partners, Kurma Partners, and Jolt Capital.